21-39765639-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080444.2(IGSF5):āc.205A>Cā(p.Ile69Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000799 in 1,613,890 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001080444.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGSF5 | NM_001080444.2 | c.205A>C | p.Ile69Leu | missense_variant | 3/9 | ENST00000380588.5 | |
IGSF5 | XM_047440699.1 | c.475A>C | p.Ile159Leu | missense_variant | 4/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGSF5 | ENST00000380588.5 | c.205A>C | p.Ile69Leu | missense_variant | 3/9 | 1 | NM_001080444.2 | P1 | |
IGSF5 | ENST00000479378.1 | n.311A>C | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251218Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135768
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461630Hom.: 1 Cov.: 34 AF XY: 0.0000454 AC XY: 33AN XY: 727132
GnomAD4 genome AF: 0.000315 AC: 48AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.205A>C (p.I69L) alteration is located in exon 3 (coding exon 3) of the IGSF5 gene. This alteration results from a A to C substitution at nucleotide position 205, causing the isoleucine (I) at amino acid position 69 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at